360 related articles for article (PubMed ID: 21932374)
1. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
Afzali A; Berry K; Ioannou GN
Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
Malik SM; Gupte PA; de Vera ME; Ahmad J
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
Wong RJ; Cheung R; Ahmed A
Hepatology; 2014 Jun; 59(6):2188-95. PubMed ID: 24375711
[TBL] [Abstract][Full Text] [Related]
5. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease.
Singal AK; Guturu P; Hmoud B; Kuo YF; Salameh H; Wiesner RH
Transplantation; 2013 Mar; 95(5):755-60. PubMed ID: 23370710
[TBL] [Abstract][Full Text] [Related]
6. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
[TBL] [Abstract][Full Text] [Related]
10. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic.
Agopian VG; Kaldas FM; Hong JC; Whittaker M; Holt C; Rana A; Zarrinpar A; Petrowsky H; Farmer D; Yersiz H; Xia V; Hiatt JR; Busuttil RW
Ann Surg; 2012 Oct; 256(4):624-33. PubMed ID: 22964732
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.
Heuer M; Kaiser GM; Kahraman A; Banysch M; Saner FH; Mathé Z; Gerken G; Paul A; Canbay A; Treckmann JW
Digestion; 2012; 86(2):107-13. PubMed ID: 22846254
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
[TBL] [Abstract][Full Text] [Related]
15. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
16. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
Seyam M; Neuberger JM; Gunson BK; Hübscher SG
Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342
[TBL] [Abstract][Full Text] [Related]
18. Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease.
Kodama K; Tokushige K; Hashimoto E; Taniai M; Shiratori K
Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E247-52. PubMed ID: 23320802
[TBL] [Abstract][Full Text] [Related]
19. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
Wong RJ; Ahmed A
Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
[TBL] [Abstract][Full Text] [Related]
20. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
Serfaty L; Lemoine M
Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
